FullHope Biomedical Co (ROCO:7773) Notes Receivable: NT$0.00 Mil (As of Dec. 2025)


ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
14 GF Score
Price NT$27.65
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co Notes Receivable?

FullHope Biomedical Co ROCO:7773 14 Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

FullHope Biomedical Co's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

FullHope Biomedical Co Notes Receivable Related Terms

FullHope Biomedical Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Notes Receivable Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ROCO:7773
14GF Score
FullHope Biomedical Co Ltd ROCO:7773
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.00 Mil mean?
FullHope Biomedical Co (ROCO:7773) has a Notes Receivable of NT$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on FullHope Biomedical Co and its competitors.
Is FullHope Biomedical Co's Notes Receivable too high?
FullHope Biomedical Co's current Notes Receivable is NT$0.00 Mil. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Notes Receivable compare to VRTX and REGN?
FullHope Biomedical Co's Notes Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Notes Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Notes Receivable of NT$0.00 Mil. The current Notes Receivable is NT$0.00 Mil. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score

Get the complete analysis for ROCO:7773

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.65
Price